Ajax Therapeutics

Targeting cancer through precise selectivity

Ajax Therapeutics was founded in 2019, is headquartered in New York, United States, lists 1–10 employees, and has $143.0M in recorded funding across 3 rounds.

Headquarters
New York, New York
Employees
1–10
Founded
2019
Business Model
B2B
Total Funding
$143.0M
Last Round
$95.0M Series CMay 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 10 investors for this company. The full record is or through the API.

About

Ajax Therapeutics is a clinical-stage biotechnology company applying computational chemistry and structural biology to develop next-generation JAK2 inhibitors for myeloproliferative neoplasms (MPNs). Their lead candidate, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical trials for myelofibrosis. The company has raised $143M from investors including Goldman Sachs, Eli Lilly, and RA Capital Management.

Summary

Ajax Therapeutics is a Biotech company based in New York, United States, founded in 2019. It lists 1–10 employees. It has raised $143.0M in total across 3 rounds, most recently a $95.0M Series C round in May 2024. Investors include EcoR1 Capital, Goldman Sachs Alternatives and OrbiMed.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMay 2024
$95.0M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ajax Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ajax-therapeutics"><img src="https://indexed.vc/api/badge/company/ajax-therapeutics" alt="Ajax Therapeutics on Indexed.vc" width="260" height="76" /></a>